Captopril and telmisartan treatments attenuate cadmium-induced testicular toxicity in rats

Fundamental and Clinical Pharmacology

Volumn 27, Issue 2, 2013, Pages 152-160

  Fouad, Amr A ^a   Jresat, Iyad ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Cadmium toxicity; Captopril; Rats; Telmisartan; Testis

Indexed keywords

CADMIUM; CAPTOPRIL; CASPASE 3; FAS LIGAND; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SELENIUM; TELMISARTAN; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; ZINC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TESTIS; TESTIS INJURY; TESTOSTERONE BLOOD LEVEL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZIMIDAZOLES; BENZOATES; CADMIUM; CADMIUM CHLORIDE; CADMIUM POISONING; CAPTOPRIL; CASPASE 3; FAS LIGAND PROTEIN; GLUTATHIONE; LIPID PEROXIDATION; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM; TESTICULAR DISEASES; TESTIS; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA; ZINC;

EID: 84874364600     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2011.00974.x     Document Type: Article

References (47)

1. Waisberg M., Joseph P., Hale B., Beyersmann D. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology (2003) 192 95-117.
2. Lauwerys R. Cadmium in man, in: Webb M. (Ed.), Chemistry, Biochemistry and Biology of Cadmium. Elsevier, Biomedical Press, Amsterdam, North Holand. 1979, pp. 1-55.
3. Gunnarsson D., Nordberg G., Lundgren P., Selstam G. Cadmium-induced decrement of the LH receptor expression and c-AMP levels in the testis of rats. Toxicology (2003) 183 57-63.
4. Yang H.S., Han D.K., Kim J.R., Sim J.C. Effects of α-tocopherol on cadmium-induced toxicity in rat testis and spermatogenesis. J. Korean Med. Sci. (2006) 21 445-451.
5. Kara H., Cevik A., Konar V., Dayangac A., Yilmaz M. Protective effect of antioxidants against cadmium-induced oxidative damage in rat testes. Biol. Trace Elem. Res. (2007) 120 205-211.
6. Yadav N., Khandelwal S. Effect of picroliv on cadmium induced testicular damage in rats. Food Chem. Toxicol. (2008) 46 494-501.
7. Fouad A.A., Qureshi H.A., Al-Sultan A.I., Yacoubi M.T., Ali A.A. Protective effect of hemin against cadmium-induced testicular damage in rats. Toxicology (2009) 257 153-160.
8. Wolf G. Angiotensin II as a mediator of tubulointerstitial injury. Nephrol. Dial. Transplant. (2000) 15 61-63.
9. Stefan F., Maclean A.A., Liu M., Kalirai B., Keshavjee S. Inhibition of angiotensin converting enzyme by captopril: a novel approach to reduce ischemia-reperfusion injury after lung transplantation. J. Thorac. Cardiovasc. Surg. (2000) 120 573-580.
10. Scribner A.W., Loscalzo J., Napol C. The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress. Eur. J. Pharmacol. (2003) 482 95-99.
11. Liu Y., You Y., Song T., Wu S., Liu L. Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril. J. Cardiovasc. Pharmacol. (2007) 50 155-161.
12. Benson S.C., Pershadsingh H.A., Ho C.I. et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity. Hypertension (2004) 43 993-1002.
13. Bolterman R.J., Manriquez M.C., Ruiz C.O.M., Juncos L.A., Romero J.C. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension (2005) 46 943-947.
14. Tsunenari I., Ohmura T., Seidler R. et al. Renoprotective effects of telmisartan in the 5/6 nephrectomised rats. J. Renin Angiotensin Aldosterone Syst. (2007) 8 93-100.
15. Morsy M., Ashour O., Amin E., Rofaeil R. Gastroprotective effects of telmisartan on experimentally-induced gastric ulcers in rats. Pharmazie (2009) 64 590-594.
16. Amirshahrokhi K., Ghazi-Khansari M., Farani M.A., Karimian G. Effect of captopril on TNF-α and IL-10 in the livers of bile duct ligated rats. Iran J. Immunol. (2010) 7 247-251.
17. Al-Shabanah O., Mansour M., El-Kashef H., Al-Bekairi A. Captopril ameliorates myocardial and hematological toxicities induced by adriamycin. Biochem. Mol. Biol. Int. (1998) 45 419-427.
18. Gupta R.S., Gupta E.S., Dhakal B.K., Thakur A.R., Ahnn J. Vitamin C and vitamin E protect the rat testes from cadmium-induced reactive oxygen species. Mol. Cells (2004) 17 132-139.
19. Franke F.E., Pauls K., Metzger R., Danilov S.M. Angiotensin I-converting enzyme and potential substrates in human testis and testicular tumours. APMIS (2003) 111 234-243.
20. Bader M., Ganten D. Update on tissue renin-angiotensin systems. J. Mol. Med. (2008) 86 615-621.
21. Davalli P., Carpenè E., Astancolle S., Viviani R., Corti A. Cadmium induction of renal and hepatic ornithine decarboxylase activity in the rat. Effects of sex hormones and involvement of the renin-angiotensin system. Biochem. Pharmacol. (1992) 44 721-726.
22. Lall S.B., Peshin S.S., Gulati K., Khattar S., Das N., Seth S.D. Involvement of renin-angiotensin system in hypertensive effect of cadmium in rats. Indian J. Exp. Biol. (1997) 35 338-391.
23. Varoni M.V., Palomba D., Macciotta N.P. et al. Brain renin-angiotensin system modifies the blood pressure response to intracerebroventricular cadmium in rats. Drug Chem. Toxicol. (2010) 33 302-309.
24. Cai H., Griendling K.K., Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. (2003) 24 471-478.
25. Souza V., Escobar Mdel C., Bucio L., Hernández E., Gómez-Quiroz L.E., Gutiérrez Ruiz M.C. NADPH oxidase and ERK1/2 are involved in cadmium induced-STAT3 activation in HepG2 cells. Toxicol. Lett. (2009) 187 180-186.
26. + exchanger and respiratory burst enzymes NADPH oxidase and NO synthase, in Cd-induced lipid peroxidation and DNA damage in haemocytes of mussels. Comp. Biochem. Physiol. C Toxicol. Pharmacol. (2010) 152 346-352.
27. Hayashi T., Takai S., Yamashita C. Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus. Curr. Vasc. Pharmacol. (2010) 8 189-197.
28. Chen L., Zhou J., Gao W., Jiang Y.Z. Action of NO and TNF-alpha release of rats with cadmium loading in malfunctiion of multiple system organ. Sheng Li Xue Bao (Acta Physiol. Sin.) (2003) 55 535-540.
29. Morris S.M. Jr, Billiar T.R. New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. (1994) 266 E829-E839.
30. Clancy R.M., Abramson S.B. Nitric oxide: a novel mediator of inflammation. Proc. Soc. Exp. Biol. Med. (1995) 210 93-101.
31. Nakamura T., Keep R.F., Hua Y., Hoff J.T., Xi G. Oxidative DNA injury after experimental intracerebral hemorrhage. Brain Res. (2005) 1039 30-36.
32. Blessing E., Preusch M., Kranzhöfer R. et al. Antiatherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice. Atherosclerosis (2008) 199 295-303.
33. Ilieva I., Ohgami K., Jin X.H. et al. Captopril suppresses inflammation in endotoxin-induced uveitis in rats. Exp. Eye Res. (2006) 83 651-657.
34. Takaya T., Kawashima S., Shinohara M. et al. Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice. Atherosclerosis (2006) 186 402-410.
35. He X., Han B., Mura M. et al. Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats. Shock (2007) 28 106-111.
36. Morishima M., Wang Y., Akiyoshi Y., Miyamoto S., Ono K. Telmisartan, an angiotensin II type 1 receptor antagonist, attenuates T-type Ca2+ channel expression in neonatal rat cardiomyocytes. Eur. J. Pharmacol. (2009) 609 105-112.
37. Oh S.H., Choi J.E., Lim S.C. Protection of betulin against cadmium-induced apoptosis in hepatoma cells. Toxicology (2006) 220 1-12.
38. Lee J., Richburg J.H., Younkin S.C., Boekelheide K. The Fas system is a key regulator of germ cell apoptosis in the testis. Endocrinology (1997) 138 2081-2088.
39. Geng J., Fan J., Jiang H.W. et al. Elevated serum soluble Fas ligand is a promising marker of testicular toxicity induced by epirubicin in rats. Toxicol. Lett. (2009) 186 96-103.
40. Shetty S., Gladden J.B., Henson E.S. et al. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NF-kappaB activation in epithelial derived cell lines. Apoptosis (2002) 7 413-420.
41. Shi Y.Q., Wang Y.P., Song Y. et al.p, p'-DDE induces testicular apoptosis in prepubertal rats via the Fas/FasL pathway. Toxicol. Lett. (2010) 193 79-85.
42. Rooney J.P. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology (2007) 234 145-156.
43. Satoh M., Shimada A., Zhang B., Tohyama C. Renal toxicity caused by cisplatinum in glutathione-depleted metallothionein-null mice. Biochem. Pharmacol. (2000) 60 1729-1734.
44. Tamba M., Torreggiani A. Free radical scavenging and copper chelation: a potentially beneficial action of captopril. Free Radic. Res. (2000) 32 199-211.
45. Pachauri V., Saxena G., Mehta A., Mishra D., Flora S.J. Combinational chelation therapy abrogates lead-induced neurodegeneration in rats. Toxicol. Appl. Pharmacol. (2009) 240 255-264.
46. Jaiswal A.K., Panda J.N., Kumar M.V., Joshi P. Androgen dependence of testicular and epididymal angiotensin converting enzyme. Andrologia (1985) 17 92-97.
47. Skoczynska A. Renin-angiotensin-aldosterone system in chronic poisoning of rats with lead and cadmium. Med. Pr. (1995) 46 239-246.